Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03425201
Title Niraparib in Combination With Cabozantinib (XL184) in Patients With Advanced Urothelial Cancer (NICARAGUA) (NICARAGUA)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Fundacion CRIS de Investigacion para Vencer el Cancer
Indications

urethra transitional cell carcinoma

transitional cell carcinoma

renal cell carcinoma

bladder urothelial carcinoma

renal pelvis transitional cell carcinoma

ureter transitional cell carcinoma

Therapies

Cabozantinib + Niraparib

Age Groups: adult | senior
Covered Countries ESP

Facility Status City State Zip Country Details
Xarxa Assistencial Universitària de Manresa Recruiting Barcelona Cataluña Spain Details
ICO Badalona Recruiting Badalona Spain Details
Hospital Clinic Recruiting Barcelona Spain Details
ICO Girona Recruiting Girona Spain Details
ICO L'Hospitalet Recruiting L'Hospitalet De Llobregat Spain Details
Hospital 12 de Octubre Recruiting Madrid Spain Details
Hospital Clinico San Carlos Withdrawn Madrid Spain Details
Hospital Madrid Norte Sanchinarro Recruiting Madrid Spain Details
Hospital Ramon y Cajal Recruiting Madrid Spain Details
Hospital Marques de Valdecilla Recruiting Santander Spain Details
Instituto Valenciano de Oncología Recruiting Valencia Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field